This study was performed to characterize the role of thyroxine (T4) in the regulation of fetal adipose tissue metabolism. On day 70 of gestation, pig fetuses were hypophysectomized (hypoxed) by microcauterization. Both hypoxed and intact fetuses were implanted subcutaneously with T4 pellets or received no hormone replacement. Fetuses were removed by laparotomy on day 90 of gestation. Additional fetuses were hypoxed on day 70, implanted with T4 pellets on day 90 and removed on day 105 of gestation. Serum T4 levels were similar in hypox + T4 and intact + T4 fetuses and increased in both groups relative to their respective controls. T4 supplementation restored the lipolytic response to isoproterenol and enhanced the response to dibutyryl cyclic AMP at 90 days in hypoxed animals but had no effect on basal or stimulated lipolysis in intact fetuses. T4 induced a dramatic increase in lipogenesis in hypoxed fetuses when administered during either fetal period and produced a slight though significant increase in basal lipogenesis in intact fetuses when administered from days 70 to 90 of gestation. However, T4 had no effect on basal or insulin-stimulated lipogenesis in intact fetuses when administered from days 90 to 105 of gestation. These results indicate that T4 may have a primary influence on fetal adipose tissue metabolism only in the absence of inhibition from counterregulatory hormones of pituitary origin.

Keywords:
Metabolism, Adipose tissue, Thyroxine, Lipolysis, Lipogenesis, Pig
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.